AU2003278559A1 - Herbal medicine containing cyclodextrins for the treatment of ear disorders - Google Patents

Herbal medicine containing cyclodextrins for the treatment of ear disorders

Info

Publication number
AU2003278559A1
AU2003278559A1 AU2003278559A AU2003278559A AU2003278559A1 AU 2003278559 A1 AU2003278559 A1 AU 2003278559A1 AU 2003278559 A AU2003278559 A AU 2003278559A AU 2003278559 A AU2003278559 A AU 2003278559A AU 2003278559 A1 AU2003278559 A1 AU 2003278559A1
Authority
AU
Australia
Prior art keywords
treatment
herbal medicine
medicine containing
ear disorders
containing cyclodextrins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003278559A
Inventor
David Nakar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAKAR HERZL
Original Assignee
NAKAR HERZL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL15234102A external-priority patent/IL152341A0/en
Application filed by NAKAR HERZL filed Critical NAKAR HERZL
Publication of AU2003278559A1 publication Critical patent/AU2003278559A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
AU2003278559A 2002-10-17 2003-10-16 Herbal medicine containing cyclodextrins for the treatment of ear disorders Abandoned AU2003278559A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IL152341 2002-10-17
IL15234102A IL152341A0 (en) 2002-10-17 2002-10-17 Pharmaceutical compositions of natural and synthetic drugs containing cyclodextrins
IL152341/2 2003-06-22
IL15234103 2003-06-22
PCT/IL2003/000840 WO2004035071A1 (en) 2002-10-17 2003-10-16 Herbal medicine containing cyclodextrins for the treatment of ear disorders

Publications (1)

Publication Number Publication Date
AU2003278559A1 true AU2003278559A1 (en) 2004-05-04

Family

ID=32109299

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003278559A Abandoned AU2003278559A1 (en) 2002-10-17 2003-10-16 Herbal medicine containing cyclodextrins for the treatment of ear disorders

Country Status (3)

Country Link
AU (1) AU2003278559A1 (en)
IL (1) IL168065A0 (en)
WO (1) WO2004035071A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20050533A1 (en) * 2005-07-29 2007-01-30 Euro Pharma S R L OTOLOGICAL SOLUTIONS BASED ON LAPACHO EXTRACTS
US20070197548A1 (en) 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
EP1842547B1 (en) * 2006-03-28 2010-01-06 Klaus Huber Pharmaceutical or nutritional supplement comprising nisyline, cepa, euphrasia, belladonna and/or mercurius solubilis
DE202006004962U1 (en) 2006-03-28 2007-08-02 Huber, Klaus, Dr.med. Use of Nisylene, Cepa, Euphrasia, Belladonna and / or Mercurius solubilis for a medicinal product
US8709501B1 (en) * 2011-07-22 2014-04-29 Beverly Jansen Method for treating wounds for mammals, wound healer compound, and method of manufacturing thereof
FR2999924B1 (en) 2012-12-21 2015-07-17 Oreal ASSEMBLY COMPRISING AT LEAST ONE ESSENTIAL OIL, A CYCLODEXTRIN AND A LIQUID FATTY BODY AND COMPOSITION CONTAINING SAME.
SE537168C2 (en) * 2013-04-16 2015-02-24 Pegion Operations Ltd Powder composition and use of said powder composition for treating a hearing disorder in mammals
JP5824704B1 (en) 2014-07-20 2015-11-25 株式会社ライラック研究所 Powder-like stagnation agent
WO2016046108A1 (en) * 2014-09-24 2016-03-31 ISTITUTO PROFILATTICO E FARMACEUTICO CANDIOLI & C. SPA in abbreviated form CANDIOLI FARMACEUTICI SPA Compositions useful for the prevention and/or treatment of infections and inflammations
CN105168421A (en) * 2015-10-24 2015-12-23 黄宇松 Method used for treating otitis media
CN113041391A (en) * 2021-03-31 2021-06-29 广州源肽生物科技有限公司 Herba centellae-collagen-containing repairing freeze-dried sponge and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU176217B (en) * 1978-11-20 1981-01-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a cyclodextrin-chamomille inclusion complex and compositions containing thereof
DE3638290A1 (en) * 1986-11-07 1988-05-19 Herbe Wirkstoffe Gmbh Pharmaceutical composition
JPH03220117A (en) * 1990-01-22 1991-09-27 Morishita Jintan Kk Composition for oral cavity
DE19746284A1 (en) * 1997-10-20 1999-04-22 Robugen Gmbh Reducing odor of camomile extract or oil by cyclodextrin treatment, useful in pharmaceuticals and/or cosmetics having antiinflammatory activity

Also Published As

Publication number Publication date
WO2004035071A1 (en) 2004-04-29
IL168065A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
AU2003286567A1 (en) Methods for the treatment of skin disorders
IL168065A0 (en) Herbal medicine containing cyclodextrins for the treatment of ear disorders
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
AU2003239474A1 (en) Device and method for the treatment of cardiac disorders
WO2003033720A8 (en) Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
AU2003233583A1 (en) Oral lactoferrin in the treatment of respiratory disorders
AU2003258305A1 (en) Combination therapy for treatment of fibrotic disorders
AU2003249983A1 (en) Piperidines useful for the treatment of central nervous system disorders
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003274342A1 (en) Compositions for the treatment of autoimmune disorders
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU6910600A (en) Methods for the treatment of mental disorders
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
AU2003291719A1 (en) Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
AU2003239361A1 (en) Customization of medical device
AU2002312897A1 (en) Drugs for the treatment of the alzheimer disease
AUPS017702A0 (en) Methods and compositions for the treatment of asthma and related disorders
AU2003223684A1 (en) Lxr modulators for the treatment of cardiovascular diseases
AU2003904328A0 (en) Diagnosis and treatment of neurodegenerative disorders
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003289652A1 (en) The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
AU2003205898A1 (en) Combination therapy for respiratory disorders
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase